Terms: = Thyroid cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
24 results:
1. Factors of Central Lymph Node Metastasis in Papillary thyroid cancer Based on C-TIRADS Analysis.
Huang W; Chen D; Zhong M; Ye J; Zhi Z; Xiao Y; Zhong Y
Horm Metab Res; 2023 Sep; 55(9):585-591. PubMed ID: 37500084
[TBL] [Abstract] [Full Text] [Related]
2. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate thyroid Nodules.
Goldner WS; Angell TE; McAdoo SL; Babiarz J; Sadow PM; Nabhan FA; Nasr C; Kloos RT
Thyroid; 2019 Nov; 29(11):1594-1605. PubMed ID: 31469053
[No Abstract] [Full Text] [Related]
4. Correlations of breast cancer fhit gene with the incidence and prognosis of breast cancer.
Fu Y; Shan X; Song W; Xu K; Jiao C; Zhang Q
J BUON; 2019; 24(1):40-47. PubMed ID: 30941950
[TBL] [Abstract] [Full Text] [Related]
5. fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
Druck T; Cheung DG; Park D; Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Raso C; Green K; Huebner K; Croce CM
Cell Death Dis; 2019 Feb; 10(3):147. PubMed ID: 30770797
[TBL] [Abstract] [Full Text] [Related]
6. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.
Son HY; Hwangbo Y; Yoo SK; Im SW; Yang SD; Kwak SJ; Park MS; Kwak SH; Cho SW; Ryu JS; Kim J; Jung YS; Kim TH; Kim SJ; Lee KE; Park DJ; Cho NH; Sung J; Seo JS; Lee EK; Park YJ; Kim JI
Nat Commun; 2017 Jul; 8():15966. PubMed ID: 28703219
[TBL] [Abstract] [Full Text] [Related]
7. Expression of fhit, p16, p53 and EGFR as prognostic markers in thyroid tumors of uncertain malignant potential.
Koc M; Aktimur R; Kagan Gokakin A; Atabey M; Koyuncu A; Elagoz S; Topcu O
J BUON; 2015; 20(2):567-72. PubMed ID: 26011351
[TBL] [Abstract] [Full Text] [Related]
8. Core needle biopsy can minimise the non-diagnostic results and need for diagnostic surgery in patients with calcified thyroid nodules.
Ha EJ; Baek JH; Lee JH; Kim JK; Kim JK; Lim HK; Song DE; Sung TY; Kim TY; Kim WB; Shong YK
Eur Radiol; 2014 Jun; 24(6):1403-9. PubMed ID: 24604217
[TBL] [Abstract] [Full Text] [Related]
9. [Incidence and mortality of cancer in Zhejiang province in 2009].
Li HZ; Mao WM; Wang XH; Yu CD; Du LB
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jul; 47(7):592-6. PubMed ID: 24304949
[TBL] [Abstract] [Full Text] [Related]
10. Systematic review with meta-analysis of prospective randomized trials comparing minimally invasive video-assisted thyroidectomy (MIVAT) and conventional thyroidectomy (CT).
Pisanu A; Podda M; Reccia I; Porceddu G; Uccheddu A
Langenbecks Arch Surg; 2013 Dec; 398(8):1057-68. PubMed ID: 24162166
[TBL] [Abstract] [Full Text] [Related]
11. DNA topoisomerases participate in fragility of the oncogene RET.
Dillon LW; Pierce LC; Lehman CE; Nikiforov YE; Wang YH
PLoS One; 2013; 8(9):e75741. PubMed ID: 24040417
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
[TBL] [Abstract] [Full Text] [Related]
13. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (fhit) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract] [Full Text] [Related]
14. Association of the promoter methylation and protein expression of Fragile Histidine Triad (fhit) gene with the progression of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen R; He G; Gao JX
Int J Clin Exp Pathol; 2010 May; 3(5):482-91. PubMed ID: 20606729
[TBL] [Abstract] [Full Text] [Related]
15. Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study.
Liang HS; Zhong YH; Luo ZJ; Huang Y; Lin HD; Luo M; ; Su HX; Zhou SB; Xie KQ
J Int Med Res; 2009; 37(3):927-38. PubMed ID: 19589279
[TBL] [Abstract] [Full Text] [Related]
16. Molecular genetic alterations of fhit and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract] [Full Text] [Related]
17. Chromosomal fragile sites fra3b and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer.
Sbrana I; Veroni F; Nieri M; Puliti A; Barale R
Genes Chromosomes Cancer; 2006 May; 45(5):429-36. PubMed ID: 16419058
[TBL] [Abstract] [Full Text] [Related]
18. Loss of heterozygosity at the fhit gene in different solid human tumours and its association with survival in colorectal cancer patients.
Petursdottir TE; Hafsteinsdottir SH; Jonasson JG; Moller PH; Thorsteinsdottir U; Huiping C; Egilsson V; Ingvarsson S
Anticancer Res; 2002; 22(6A):3205-12. PubMed ID: 12530066
[TBL] [Abstract] [Full Text] [Related]
19. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract] [Full Text] [Related]
20. fhit and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract] [Full Text] [Related]
[Next]
